Myeloproliferative Neoplasms

Top Story

ASH announces award recipients

July 15, 2019

St. Jude Children’s Research Hospital physician-scientist receives award

July 12, 2019
Esther Obeng, MD, PhD, received the 2019 Gertrude B. Elion Cancer Research Award from American Association for Cancer Research. The award supports early-career…
In the JournalsPerspective

Next-generation hypomethylating agent shows promise for intermediate-, high-risk myelodysplastic syndrome

July 11, 2019
Guadecitabine demonstrated clinical activity with acceptable toxicity among patients with intermediate- and high-risk myelodysplastic syndrome, according to randomized…
Feature

Dana-Farber clinic to focus on blood cancer precursor conditions

June 28, 2019
Dana-Farber Cancer Institute opened a new clinic designed to improve clinical care and monitoring for individuals with precursor conditions that can progress to blood…
More Headlines »
CME

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years…
More »
Video
Meeting News Coverage

Video: Researchers ‘eagerly await’ final data on pegylated interferon for myeloproliferative neoplasms

December 14, 2016
More »
CME CNE

Focus on Advancing Treatment for Acute Myeloid Leukemia

This activity is supported by an independent educational grant from Pfizer, Inc.

In this activity, Bruno Medieros, MD, and Farhad Ravandi-Kashini, MD, discuss recent advances in the treatment of acute…
More »